开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2024-03-15 12023a71m61暂无昵称来自新疆

很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！

64 0

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2023-12-01 ms1000001598442016 来自黑龙江省

偏重的研究方向：骨科
经验分享：投稿后第一天就回复让转投了，挺快

71 0

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2022-05-01 146f3421m19(暂无昵称)

审稿速度:12.0
偏重的研究方向：骨科创伤;骨科临床研究
经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。

126 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2022-05-11 12312345567890

审稿速度:1.0 | 投稿命中率:5.0
经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复

117 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2016-09-30 memeclee

审稿速度:2.0 | 投稿命中率:50.0
经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。

468 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2017-09-02 carl97

审稿速度:2.0 | 投稿命中率:50.0
经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大

368 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2018-01-03 1e16609dm11(暂无匿称)

请问要meta么LiDh9090 2016-08-28 16:49:00 发表:
这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.

LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.

199 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2021-09-25 ms3000000534700024

审稿速度:2.0
偏重的研究方向：骨科
经验分享：投稿不到两月，目前已接收

141 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2022-06-16 ms6000001522264603

请问接受骨质疏松方向文章吗

104 0

[GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历，投稿后1个月小修，审稿人建议接收，主编给了一个小小的意见。稳妥起见，查阅大量了一些文献后，对文章进行了仔细修改。修回后第二天，直接拒稿，说是稿件质量不高，不符合初审标准，建议转投脊柱外科专科期刊！气得我连夜进行了申诉，一周内发了三次申诉信，但是并未得到任何回应！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向：骨科 经验分享：投稿后第一天就回复让转投了，挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了1篇，2小时拒稿，没有审稿意见，现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初审很严格，质量不佳的基本秒拒，有一篇1天悲剧。另一篇，2月大修，意见友善，大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

2022-04-07 ms8000000975709473

该期刊要求的参考文献格式是endnote中的那种格式形式？？？

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务